Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 16, Issue 4, Pages 444-453
Publisher
Wiley
Online
2013-12-31
DOI
10.1002/ejhf.47
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Pulmonary Hypertension Caused by Left Heart Failure With Pulmonary Arterial Hypertension–Specific Therapies
- (2013) Lewis J. Rubin CIRCULATION
- Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension
- (2013) Steven G. Chrysant CURRENT HYPERTENSION REPORTS
- Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
- (2013) F. P. Brouwers et al. EUROPEAN HEART JOURNAL
- PDE5 inhibitors: considerations for preference and long-term adherence
- (2013) W. B. Smith et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differences in Hemodynamic Parameters and Exercise Capacity Between Patients With Pulmonary Arterial Hypertension and Chronic Heart Failure
- (2013) Ryo Nishio et al. Journal of Cardiopulmonary Rehabilitation and Prevention
- Effects of Phosphodiesterase Type 5 Inhibition on Systemic and Pulmonary Hemodynamics and Ventricular Function in Patients With Severe Symptomatic Aortic Stenosis
- (2012) Brian R. Lindman et al. CIRCULATION
- Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle
- (2012) Marinus A.J. Borgdorff et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sildenafil in Heart Failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and design
- (2012) Trond J. Cooper et al. EUROPEAN JOURNAL OF HEART FAILURE
- Pulmonary hypertension due to left heart disease: Updated Recommendations of the Cologne Consensus Conference 2011
- (2012) Stephan Rosenkranz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: A case–control study
- (2012) Adrian Reichenbach et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cyclic Guanosine Monophosphate Signaling and Phosphodiesterase-5 Inhibitors in Cardioprotection
- (2012) Rakesh C. Kukreja et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
- (2011) Marco Guazzi et al. CIRCULATION
- Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study
- (2011) Marco Guazzi et al. EUROPEAN JOURNAL OF HEART FAILURE
- Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension
- (2011) Daniel Dumitrescu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart
- (2010) Zhongbing Lu et al. CIRCULATION
- PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure
- (2010) Marco Guazzi et al. Circulation-Heart Failure
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
- (2010) Lawrence G. Rudski et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling
- (2009) S. Schafer et al. CARDIOVASCULAR RESEARCH
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
- (2009) et al. EUROPEAN HEART JOURNAL
- Acute Hemodynamic Effects of Intravenous Sildenafil Citrate in Congestive Heart Failure: Comparison of Phosphodiesterase Type-3 and -5 Inhibition
- (2009) Phil Botha et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
- (2009) Carolyn S.P. Lam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Determinants of Ventilatory Efficiency in Heart Failure
- (2008) Gregory D. Lewis et al. Circulation-Heart Failure
- Effects of 5′-Phosphodiesterase Four-Week Long Inhibition With Sildenafil in Patients With Chronic Heart Failure: A Double-Blind, Placebo-Controlled Clinical Trial
- (2008) Alice Behling et al. JOURNAL OF CARDIAC FAILURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search